Results from the 2002-03 Palivizumab Outcomes Registry: focus on congenital airway abnormalities & neuromuscular disease. 2004 Pediatric Academic Societies Meeting
Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics